IP Library Granted Patent US 10,442,182
Granted Patent B2
US 10,442,182 · App. 15/360,788 · Granted Oct 15, 2019

In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing

Inventors: Venu G. Varanasi (Dallas, TX); Azhar Ilyas (Arlington, TX); Philip Roger Kramer (Dallas, TX); Taha Azimaie (Dallas, TX); Pranesh B. Aswath (Grapevine, TX); Tugba Cebe (Grapevine, TX)
Assignees: The Texas A&M University System; The Board of Regents, The University of Texas System
B33Y70/00A61K31/722A61K33/00A61K38/39A61K41/00A61N5/062B29C64/106B33Y10/00B33Y80/00A61N2005/0661B29K2067/046B29K2995/0056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,442,182
App. No.
15/360,788
Filed
Nov 23, 2016
Granted
Oct 15, 2019
Kind
B2
Art Unit
3775
USPC
606/86R
Abstract

Bio-Inks and methods of using compositions comprising the bio-Inks are disclosed. 3-D tissue repair and regeneration through precise and specific formation of biodegradable tissue scaffolds in a tissue site using the bio-inks are also provided. Specific methylacrylated gelatin hydrogels (MAC) and methacrylated chitosan (MACh) preparations formulated with sucrose, a silicate-containing component (such as laponite), and/or a cross-linking agent (such as a photo-initiator or chemical initiator), as well as powdered preparations of these, are also disclosed. Kits containing these preparations are provided for point-of-care tissue repair in vivo. Superior, more complete (up to 99.85% tissue regeneration within 4 weeks applied in situ), and rapid in situ tissue repair and bone formation are also demonstrated.

Claims (10)

1. A method for providing tissue repair in vivo comprising;

combining a first preparation comprising a freeze-dried preparation of a MAG or MACh material with a second preparation comprising sucrose, a silicate based nanoparticle material, and a biocompatible, non-toxic cross-linking agent, to provide a pharmacologically acceptable extrudable composition;

applying the extrudable preparation to a defined tissue region having a defined in vivo target area of soft tissue or bone tissue deficiency in an animal;

exposing the pharmaceutical composition in the defined in vivo target area to a physiologically acceptable wavelength and intensity of ultra violet light for a period of time sufficient to promote polymer cross-linking and formation of filaments; and

providing tissue repair to the defined in vivo target area in the animal.

2. The method of claim 1 wherein the in vivo target area is a bone fracture.

3. The method of claim 1 wherein the biocompatible, non-toxic cross-linking agent is 2-hydroxy-1-(4-(hydroxyethoxy) phenyl) 2-methyl-1-propanone.

4. The method of claim 2 wherein the physiologically acceptable wavelength of ultraviolet light is a 365 nm UV light illumination at an intensity of up to 50 mW/sq. cm.

5. The method of claim 1 wherein the extrudable preparation is applied in a defined series of more than one layer to provide a mesh configuration over the defined in vivo target area.

6. The method of claim 4 wherein the extrudable preparation comprises about 1% to about 20% wt. of methacrylated gelatin (MAG) or methacrylated chitosan (MACh), about 2% to about 8% silicate-based nanoparticles, and about 5% to about 20% sucrose.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2018
From: CEBE, TUGBA
To: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 047507/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2018
From: VARANASI, VENU G.; ILYAS, AZHAR; KRAMER, PHILIP ROGER; AZIMAIE, TAHA
To: THE TEXAS A&M UNIVERSITY SYSTEM
Reel/Frame 046200/0647 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2018
From: ASWATH, PRANESH B.
To: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 046200/0709 →
CONFIRMATORY LICENSE Recorded Dec 14, 2017
From: TEXAS A&M UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044876/0559 →
Continuity (2)
Provisional Application 62259556 · Nov 24, 2015
Related Publication 20170143831A1 · May 25, 2017
Cited By (2)
US 12,433,769 US 12,661,230